Net Medical Xpress Solutions, Inc. (NMXS)
OTCMKTS
· Delayed Price · Currency is USD
0.0031
0.00 (0.00%)
At close: May 13, 2025
NMXS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2007 - 2011 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '17 Sep 30, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2007 - 2011 |
Operating Revenue | 2.68 | 3.05 | 4.22 | 4.58 | 4.81 | 3.91 | Upgrade
|
Revenue | 2.68 | 3.05 | 4.22 | 4.58 | 4.81 | 3.91 | Upgrade
|
Revenue Growth (YoY) | -17.41% | -27.88% | -7.88% | -4.74% | 23.20% | 21.77% | Upgrade
|
Cost of Revenue | 1.99 | 2.27 | 3.06 | 3.77 | 3.65 | 2.98 | Upgrade
|
Gross Profit | 0.69 | 0.77 | 1.17 | 0.82 | 1.16 | 0.92 | Upgrade
|
Selling, General & Admin | 0.82 | 0.94 | 0.89 | 1.07 | 0.94 | 0.81 | Upgrade
|
Research & Development | 0.08 | 0.09 | 0.1 | 0.12 | 0.16 | 0.07 | Upgrade
|
Other Operating Expenses | - | - | - | - | - | -0 | Upgrade
|
Operating Expenses | 0.9 | 1.03 | 1.01 | 1.28 | 1.12 | 0.91 | Upgrade
|
Operating Income | -0.21 | -0.26 | 0.16 | -0.47 | 0.04 | 0.02 | Upgrade
|
Interest Expense | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | Upgrade
|
EBT Excluding Unusual Items | -0.22 | -0.26 | 0.15 | -0.48 | 0.03 | 0.01 | Upgrade
|
Impairment of Goodwill | -0.08 | -0.08 | - | - | - | - | Upgrade
|
Pretax Income | -0.3 | -0.34 | 0.15 | -0.48 | 0.03 | 0.01 | Upgrade
|
Net Income | -0.3 | -0.34 | 0.15 | -0.48 | 0.03 | 0.01 | Upgrade
|
Net Income to Common | -0.3 | -0.34 | 0.15 | -0.48 | 0.03 | 0.01 | Upgrade
|
Net Income Growth | - | - | - | - | 500.00% | - | Upgrade
|
Shares Outstanding (Basic) | 19 | 19 | 19 | 18 | 18 | 17 | Upgrade
|
Shares Outstanding (Diluted) | 19 | 19 | 20 | 18 | 18 | 17 | Upgrade
|
Shares Change (YoY) | 0.13% | -5.03% | 12.03% | - | 9.78% | 2.84% | Upgrade
|
EPS (Basic) | -0.02 | -0.02 | 0.01 | -0.03 | 0.00 | 0.00 | Upgrade
|
EPS (Diluted) | -0.02 | -0.02 | 0.01 | -0.03 | 0.00 | 0.00 | Upgrade
|
EPS Growth | - | - | - | - | 448.00% | - | Upgrade
|
Free Cash Flow | -0.19 | -0.08 | 0.13 | -0.2 | 0.23 | -0.07 | Upgrade
|
Free Cash Flow Per Share | -0.01 | -0.00 | 0.01 | -0.01 | 0.01 | -0.00 | Upgrade
|
Gross Margin | 25.76% | 25.32% | 27.64% | 17.85% | 24.13% | 23.64% | Upgrade
|
Operating Margin | -8.00% | -8.37% | 3.79% | -10.17% | 0.87% | 0.43% | Upgrade
|
Profit Margin | -11.33% | -11.30% | 3.58% | -10.52% | 0.62% | 0.13% | Upgrade
|
Free Cash Flow Margin | -7.07% | -2.63% | 3.06% | -4.36% | 4.86% | -1.69% | Upgrade
|
EBITDA | -0.21 | -0.24 | 0.18 | -0.44 | 0.07 | 0.05 | Upgrade
|
EBITDA Margin | -7.92% | -7.98% | 4.36% | -9.58% | 1.41% | 1.15% | Upgrade
|
D&A For EBITDA | 0 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 | Upgrade
|
EBIT | -0.21 | -0.26 | 0.16 | -0.47 | 0.04 | 0.02 | Upgrade
|
EBIT Margin | -8.00% | -8.37% | 3.79% | -10.17% | 0.87% | 0.43% | Upgrade
|
Revenue as Reported | 2.68 | 3.05 | 4.22 | 4.58 | 4.81 | 3.91 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.